Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion type Assertion NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_head.
- NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion wasGeneratedBy ECO_0000203 NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_provenance.
- NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion wasDerivedFrom befree-2016 NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_provenance.
- NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion SIO_000772 15593184 NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_provenance.
- NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion evidence source_evidence_literature NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_provenance.
- NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_assertion description "[MTX, SSZ, infliximab, and IL-4 each inhibited the expression of RANKL in RA FLS in a dose-dependent manner, and also increased the secretion of OPG in RA FLS supernatants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472486.RA4VJ9nIVEbbbXL77aVS1Y3wdR19padDlVJn4kiNHutlg130_provenance.